547 related articles for article (PubMed ID: 29277566)
1. Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival.
Friebus-Kardash J; Wilde B; Keles D; Heinold A; Kribben A; Witzke O; Heinemann FM; Eisenberger U
Transpl Immunol; 2018 Apr; 47():10-17. PubMed ID: 29277566
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
3. Soluble BAFF Cytokine Levels and Antibody-Mediated Rejection of the Kidney Allograft.
Slavcev A; Brozova J; Slatinska J; Sekerkova Z; Honsova E; Skibova J; Striz I; Viklicky O
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):47-53. PubMed ID: 28083608
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
5. Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation.
Salvadé I; Aubert V; Venetz JP; Golshayan D; Saouli AC; Matter M; Rotman S; Pantaleo G; Pascual M
Hum Immunol; 2016 Jun; 77(6):483-9. PubMed ID: 27085791
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S
Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960
[TBL] [Abstract][Full Text] [Related]
7. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
[TBL] [Abstract][Full Text] [Related]
8. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic polymorphisms of macrophage inhibitory factor (MIF) and B-cell activating factor (BAFF) with the detection of donor specific antibodies in kidney allograft recipients.
Chang Y; Shah T; Min DI
Hum Immunol; 2017 Oct; 78(10):621-628. PubMed ID: 28624489
[TBL] [Abstract][Full Text] [Related]
10. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
11. Peripheral B-cell phenotype and BAFF levels are associated with HLA immunization in patients awaiting kidney transplantation.
Snanoudj R; Candon S; Roelen DL; Jais JP; Claas FH; Legendre C; Chatenoud L
Transplantation; 2014 May; 97(9):917-24. PubMed ID: 24827764
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients.
Zhang Q; Hickey M; Drogalis-Kim D; Zheng Y; Gjertson D; Cadeiras M; Khuu T; Baas AS; Depasquale EC; Halnon NJ; Perens G; Alejos J; Cruz D; Ali N; Shemin R; Kwon M; Fishbein MC; Ardehali A; Deng M; Reed EF
Transplantation; 2018 Oct; 102(10):e431-e438. PubMed ID: 29916988
[TBL] [Abstract][Full Text] [Related]
13. Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients.
Staeck A; Khadzhynov D; Kleinsteuber A; Lehner L; Duerr M; Budde K; Lachmann N; Halleck F; Staeck O
Transpl Immunol; 2020 Dec; 63():101333. PubMed ID: 32919027
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
[TBL] [Abstract][Full Text] [Related]
15. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
[TBL] [Abstract][Full Text] [Related]
16. Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.
Musat AI; Pigott CM; Ellis TM; Agni RM; Leverson GE; Powell AJ; Richards KR; D'Alessandro AM; Lucey MR
Liver Transpl; 2013 Oct; 19(10):1132-41. PubMed ID: 23873778
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
18. The results of HLA-incompatible kidney transplantation according to pre-transplant crossmatch tests: Donor-specific antibody as a prominent predictor of acute rejection.
Kwon H; Kim YH; Kim JY; Choi JY; Shin S; Jung JH; Park SK; Han DJ
Clin Transplant; 2019 May; 33(5):e13533. PubMed ID: 30864255
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients.
Min JW; Kim KW; Kim BM; Doh KC; Choi MS; Choi BS; Park CW; Yang CW; Kim YS; Oh EJ; Chung BH
PLoS One; 2016; 11(9):e0162964. PubMed ID: 27631619
[TBL] [Abstract][Full Text] [Related]
20. Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection.
Banham G; Prezzi D; Harford S; Taylor CJ; Hamer R; Higgins R; Bradley JA; Clatworthy MR
Transplantation; 2013 Aug; 96(4):413-20. PubMed ID: 23842189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
